Therapeutic potential of Ca2.3 inhibitors in CDD mouse and human models

Awardee: Marisol Sampedro Castanedo, PhD

Institution: Francis Crick Institute

Award Amount: $149,942.00

Funding Period: May 1, 2023 - April 31, 2024

Previous
Previous

Assessment of the therapeutic potential of TATk-hCDKL5 isoform 1 and 2 produced in recombinant Antarctic Pseudoalteromonas haloplanktis TAC125

Next
Next

Clinical trial for antisense oligonucleotide therapy in a patient with ADLD